163 related articles for article (PubMed ID: 21211677)
1. [Fabry disease: enzymatic screening using dried blood spots on filter paper].
Caudron E; Germain DP; Prognon P
Rev Med Interne; 2010 Dec; 31 Suppl 2():S263-9. PubMed ID: 21211677
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic diagnosis of Fabry disease using a fluorometric assay on dried blood spots: An alternative methodology.
Caudron E; Prognon P; Germain DP
Eur J Med Genet; 2015 Dec; 58(12):681-4. PubMed ID: 26520229
[TBL] [Abstract][Full Text] [Related]
3. Diagnosing lysosomal storage disorders: Fabry disease.
Bodamer OA; Johnson B; Dajnoki A
Curr Protoc Hum Genet; 2013; Chapter 17():Unit17.13. PubMed ID: 23595598
[TBL] [Abstract][Full Text] [Related]
4. Fabry disease: a new approach for the screening of females in high-risk groups.
Pasqualim G; Simon L; Sperb-Ludwig F; Burin MG; Michelin-Tirelli K; Giugliani R; Matte U
Clin Biochem; 2014 May; 47(7-8):657-62. PubMed ID: 24582695
[TBL] [Abstract][Full Text] [Related]
5. α-Galactosidase A/lysoGb3 ratio as a potential marker for Fabry disease in females.
Baydakova GV; Ilyushkina AA; Moiseev S; Bychkov IO; Nikitina NV; Buruleva ТА; Zakharova EY
Clin Chim Acta; 2020 Feb; 501():27-32. PubMed ID: 31770509
[TBL] [Abstract][Full Text] [Related]
6. Whole-blood alpha-D-galactosidase A activity for the identification of Fabry's patients.
Massaccesi L; Burlina A; Baquero CJ; Goi G; Burlina AP; Tettamanti G
Clin Biochem; 2011 Jul; 44(10-11):916-21. PubMed ID: 21515249
[TBL] [Abstract][Full Text] [Related]
7. Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry.
Dajnoki A; Fekete G; Keutzer J; Orsini JJ; De Jesus VR; Chien YH; Hwu WL; Lukacs Z; Mühl A; Zhang XK; Bodamer O
Clin Chim Acta; 2010 Oct; 411(19-20):1428-31. PubMed ID: 20338160
[TBL] [Abstract][Full Text] [Related]
8. Effect of sample collection on alpha-galactosidase A enzyme activity measurements in dried blood spots on filter paper.
Olivova P; van der Veen K; Cullen E; Rose M; Zhang XK; Sims KB; Keutzer J; Browning MF
Clin Chim Acta; 2009 May; 403(1-2):159-62. PubMed ID: 19245803
[TBL] [Abstract][Full Text] [Related]
9. Targeted Screening of Fabry Disease in Male Hemodialysis Patients in Brazil Highlights Importance of Family Screening.
Silva CA; Barreto FC; Dos Reis MA; Moura Junior JA; Cruz CM
Nephron; 2016; 134(4):221-230. PubMed ID: 27576502
[TBL] [Abstract][Full Text] [Related]
10. Effect of single-nucleotide polymorphisms of the 5' untranslated region of the human α-galactosidase gene on enzyme activity, and their frequencies in Portuguese caucasians.
Oliveira JP; Ferreira S; Barceló J; Gaspar P; Carvalho F; Sá Miranda MC; Månsson JE
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S247-53. PubMed ID: 18979223
[TBL] [Abstract][Full Text] [Related]
11. Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers.
Linthorst GE; Vedder AC; Aerts JM; Hollak CE
Clin Chim Acta; 2005 Mar; 353(1-2):201-3. PubMed ID: 15698608
[TBL] [Abstract][Full Text] [Related]
12. Immunoquantification of alpha-galactosidase: evaluation for the diagnosis of Fabry disease.
Fuller M; Lovejoy M; Brooks DA; Harkin ML; Hopwood JJ; Meikle PJ
Clin Chem; 2004 Nov; 50(11):1979-85. PubMed ID: 15364892
[TBL] [Abstract][Full Text] [Related]
13. A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient population.
Merta M; Reiterova J; Ledvinova J; Poupetová H; Dobrovolny R; Rysavá R; Maixnerová D; Bultas J; Motán J; Slivkova J; Sobotova D; Smrzova J; Tesar V
Nephrol Dial Transplant; 2007 Jan; 22(1):179-86. PubMed ID: 17040996
[TBL] [Abstract][Full Text] [Related]
14. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation.
Okur I; Ezgu F; Biberoglu G; Tumer L; Erten Y; Isitman M; Eminoglu FT; Hasanoglu A
Gene; 2013 Sep; 527(1):42-7. PubMed ID: 23756194
[TBL] [Abstract][Full Text] [Related]
15. Comparison between alpha-galactosidase A activity in blood samples collected on filter paper, leukocytes and plasma.
Daitx VV; Mezzalira J; Goldim MP; Coelho JC
Clin Biochem; 2012 Oct; 45(15):1233-8. PubMed ID: 22569598
[TBL] [Abstract][Full Text] [Related]
16. A tandem mass spectrometry triplex assay for the detection of Fabry, Pompe, and mucopolysaccharidosis-I (Hurler).
Duffey TA; Bellamy G; Elliott S; Fox AC; Glass M; Turecek F; Gelb MH; Scott CR
Clin Chem; 2010 Dec; 56(12):1854-61. PubMed ID: 20940330
[TBL] [Abstract][Full Text] [Related]
17. Testing the feasibility of fully automated chip-based nanoelectrospray ionization mass spectrometry as a novel tool for rapid diagnosis of Fabry disease.
Flangea C; Mosoarca C; Cozma C; Galusca M; Przybylski M; Zamfir AD
Electrophoresis; 2013 Jun; 34(11):1572-80. PubMed ID: 23483567
[TBL] [Abstract][Full Text] [Related]
18. Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches.
Germain DP; Poenaru L
Biochem Biophys Res Commun; 1999 Apr; 257(3):708-13. PubMed ID: 10208848
[TBL] [Abstract][Full Text] [Related]
19. [Contribution of the measurement of globotriaosylceramide in urine to the diagnosis and follow-up of Fabry disease].
Piraud M; Maire I; Froissart R
Rev Med Interne; 2010 Dec; 31 Suppl 2():S270-4. PubMed ID: 21211678
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of Fabry Disease Using Alpha-Galactosidase A Activity or LysoGb3 in Blood Fails to Identify Up to Two Thirds of Female Patients.
Duro G; Anania M; Zizzo C; Francofonte D; Giacalone I; D'Errico A; Marsana EM; Colomba P
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
